Prevalence of multiple myeloma

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/104329
• EU PAS number:
  EUPAS104328
• Study ID:
  104329
• Official title and acronym:
  Prevalence of multiple myeloma
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  United Kingdom
• Study description:
  A descriptive study to determine the complete prevalence of Multiple Myeloma in electronic health records of three European countries
• Study status:
  Finalised

Research institution and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 03/02/2022

Actual: 03/02/2022

Study start date

Planned: 03/02/2022

Actual: 03/02/2022

Date of final study report

Planned: 15/03/2022

Actual: 13/05/2022

Sources of funding

EMA

Study protocol

Initial protocol

Data analysis plan - Multiple Myeloma - 20220224 - v1_For Publication_CLEAN

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable